NIH-funded research R01 grant

Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen

Official title: Adapting flow cytometry methods for early detection of acute hematologic malignancies in Kenya including the improvement of sample flow processes and technical training of personnel

Funded at Indiana University Indianapolis · NIH-11622490 · Data updated 2026-11-12

A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startJuly 2, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$283,555
NIH project number3R01CA278862-03S1
Project IDNIH-11622490 on NIH RePORTER

Who could benefit from this research

Could help

Children and young adults in Kenya with suspected leukemias or lymphomas who could benefit from a less invasive, blood-based screening.

Less likely to help

Patients with cancers not detectable by the proposed flow cytometry markers or those needing immediate comprehensive diagnostic workups may not benefit.

What this research studies

This project will adapt existing flow cytometry methods to a single-tube peripheral blood test for initial leukemia screening in Kenya, reducing the need for invasive bone marrow procedures. It compares bone marrow and blood samples to validate a streamlined, affordable approach that can be performed near the patient. If a patient’s test suggests malignancy, only a small subset would undergo further testing. The effort includes training local personnel to perform and interpret the test, helping build local capacity for cancer diagnostics.

Why it matters

Potential benefit: If successful, more children and young adults in Kenya could receive faster, affordable leukemia screening closer to home.

How similar studies have gone: Previous flow cytometry efforts show promise in leukemia diagnostics, but this approach emphasizes a cheaper, blood-based single-tube screen applicable in low-resource settings.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Vik, Terry a — Indiana University Indianapolis
  • Study coordinator: Vik, Terry a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.